The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial.
 
Ming-Huang Chen
No Relationships to Disclose
 
June-Seng Lin
No Relationships to Disclose
 
Chin-Fu Hsiao
No Relationships to Disclose
 
Yan-Shen Shan
No Relationships to Disclose
 
Yeu-Chin Chen
No Relationships to Disclose
 
Li-Tzong Chen
No Relationships to Disclose
 
Tsang-Wu Liu
No Relationships to Disclose
 
Chung-Pin Li
No Relationships to Disclose
 
Yee Chao
No Relationships to Disclose